Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Understand how volatility risk affects retirement portfolios by comparing Total Market and S&P 500 exposure. This intro explains why broad market allocation matters for steady growth.
28,559 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
As investors weigh potential Fed easing, the EDV ETF could surge on falling long-term yields. Here's what to know abo...
Jim Cramer signals a clear pecking order in payments, naming Klarna as the one to avoid while highlighting Affirm and...
New Jersey’s real estate scene is buzzing even with steep taxes and living costs. This article breaks down the demand...
Barclays and Truist each updated price targets for Carnival ahead of the March 27, 2026 Q1 release, signaling a split...
Unpack the essential takeaways from MASS's hypothetical Q4 2025 earnings. Learn how to read the transcript, spot marg...
As quantum dreams grow from labs to law and logistics, Rigetti's domestic footprint and government ties could propel ...
Alphabet is trading in the mid‑$300s as AI monetization and cloud expansion threaten to carry momentum into the secon...
Lucid Group has ambitious plans, but shifting from carmaker to tech supplier brings new risks. This article explains ...
A surge of commentary in crypto circles centers on XRP's function within Ripple's rails, pitting advocates of open fi...
This guide breaks down the dynatrace (dt) 2026 earnings narrative for investors. It covers growth drivers, margins, g...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...